`
`
`
`No. 2019-2302, 2019-2303, 2019-2304, 2019-2305, 2019-2452
`
`UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
`
`The Trustees of Columbia University in the City of New York,
`
`v.
`
`Illumina, Inc.,
`
`Appellant,
`
`Appellee.
`
`Appeals from the United States Patent and Trademark Office,
`Patent Trial and Appeal Board in Nos. IPR2018-00291,
`IPR2018-00318, IPR2018-00322, IPR2018-00385, and IPR2018-00797
`
`
`REPLY IN SUPPORT OF APPELLANT’S
`MOTION FOR JUDICIAL NOTICE
`
`John D. Murnane
`Robert S. Schwartz
`Justin J. Oliver
`Zachary L. Garrett
`VENABLE LLP
`1290 Avenue of the Americas
`New York, NY 10104
`212-218-2100
`
`John P. White
`COOPER & DUNHAM LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`212-278-0400
`
`
`
`Illumina Ex. 1166
`Illumina v. Columbia
`IPR2020-01177
`
`
`
`Case: 19-2302 Document: 54 Page: 2 Filed: 10/02/2020
`
`
`
`CERTIFICATE OF INTEREST
`
`Counsel for The Trustees of Columbia University in the City of New York
`
`certifies the following:
`
`1. The full name of every party or amicus represented by me is:
`
`• The Trustees of Columbia University in the City of New York.
`
`2. The real party in interest is:
`
`• The Trustees of Columbia University in the City of New York.
`
`3. All parent corporations and any publicly held companies that own 10% or
`
`more of the stock of the parties I represent are:
`
`• None.
`
`4. The names of all law firms and the partners or associates that appeared for
`
`the parties now represented by me in the trial court or are expected to appear in this
`
`court (and who have not or will not enter an appearance in this case) are:
`
`• Cooper & Dunham: Gary J. Gershik;
`
`• Morris, Nichols, Arsht & Tunnell: Jack B. Blumenfeld; Maryellen
`Noreika (now Judge Maryellen Noreika).
`
`5. The title and number of any case known to counsel to be pending in this or
`
`any other court or agency that will directly affect or be directly affected by this
`
`Court’s decision in the pending appeal:
`
`• The Trustees of Columbia University in the City of New York et al. v.
`Illumina, Inc., 17-cv-00973 (D. Del.)
`
`
`
`i
`
`
`
`Case: 19-2302 Document: 54 Page: 3 Filed: 10/02/2020
`
`
`
`I.
`
`ARGUMENT
`
`Illumina waited until the briefing period in these appeals was over before
`
`filing the IPR2020-00988 documents, toward the end of its 1-year filing window.
`
`Illumina’s statements in those documents are relevant to these appeals, and
`
`Columbia should be permitted to address those statements at the upcoming oral
`
`argument.
`
`Illumina opposes Columbia’s request by mischaracterizing the law in a
`
`manner that would all but negate this Court’s ability to take judicial notice.
`
`Illumina contends that while this Court can take judicial notice of the fact that a
`
`document was filed, it cannot further notice the contents of the filed document.
`
`That is wrong. Federal Rule of Evidence 201 permits judicial notice to be taken of
`
`any fact “that is not subject to reasonable dispute because” it “can be accurately
`
`and readily determined from sources whose accuracy cannot reasonably be
`
`questioned.” In IPR2020-00988, Illumina filed with the Patent Trial and Appeal
`
`Board (“PTAB”) a Petition and Expert Declaration. The indisputable fact is that
`
`Illumina and its expert made the statements in those documents, including the
`
`statements that Columbia wishes to bring to this Court’s attention. See Columbia’s
`
`Motion, D.I. 51 at 3 (quoting statements). Anyone can go the PTAB’s website,
`
`download the documents in question, which were submitted by Illumina, and
`
`confirm the existence of those statements.
`
`
`
`
`1
`
`
`
`Case: 19-2302 Document: 54 Page: 4 Filed: 10/02/2020
`
`
`
`It is well within this Court’s ability to take judicial notice of statements
`
`made in documents filed in district court and Patent Office proceedings. In LA
`
`Biomed, this Court took judicial notice of the contents of infringement contentions
`
`filed in a district court litigation. Los Angeles Biomedical Res. Inst. at Harbor-
`
`UCLA Med. Ctr. v. Eli Lilly & Co., 849 F.3d 1049, 1061, 1061 n.6 (Fed. Cir.
`
`2017). Illumina contends that the Court in LA Biomed noticed only that the
`
`contentions were filed, as opposed to noticing statements found therein. D.I. 53 at
`
`3 n.1. That is wrong. After taking judicial notice, this Court explicitly considered,
`
`and even quoted, statements in the contentions:
`
`Nor do LAB’s infringement contentions in the ongoing district court
`case render the “arresting or regressing” limitation irrelevant…. LAB
`alleged that the “[l]ong-term administration of Cialis on a once daily
`basis for the treatment of [erectile dysfunction] results in the arrest or
`regression of penile tunical fibrosis (i.e., [Peyronie’s disease]) and
`corporal tissue fibrosis (i.e., [CVOD]).” [LAB]’s Disclosure of
`Asserted Claims and Preliminary Infringement Contentions, Ex. A at
`5, Los Angeles Biomed. Research Inst. v. Eli Lilly & Co., No. 2:13-cv-
`08567-JAK-JCG (C.D. Cal. filed May 19, 2014).
`
`849 F.3d at 1061-1062 (brackets in original); see also St. Clair Intellectual Prop.
`
`Consultants, Inc. v. Canon Inc., 412 F. App’x 270, 275-276, 275 n.1 (Fed. Cir.
`
`2011) (considering remarks made in documents before the Patent and Trademark
`
`Office after taking judicial notice of those documents).
`
`Illumina also mischaracterizes Uniloc, a case in which this Court took
`
`judicial notice of a patent’s prosecution history and then cited the contents of that
`
`
`
`
`2
`
`
`
`Case: 19-2302 Document: 54 Page: 5 Filed: 10/02/2020
`
`
`
`history. Uniloc USA, Inc. v. ADP, LLC, 772 F. App’x 890, 897-898, 898 n.3 (Fed.
`
`Cir. 2019). Illumina alleges that the Uniloc “Court was clear that the prosecution
`
`history was part of the record[,]” D.I. 53 at 3 n.1, but that is wrong and illogical. If
`
`the prosecution history were part of the record being appealed, there would have
`
`been no need for the Court to take judicial notice of it. Instead, this Court stated
`
`that the prosecution history was “a matter of public record,” not that it was part of
`
`the record being appealed. 772 F. App’x at 898 n.3 (internal quotations and
`
`brackets omitted, emphasis added). Likewise, the IPR2020-00988 documents at
`
`issue here are a matter of public record, verifiable by anyone who wishes to
`
`download the documents from the PTAB’s website.
`
`Beyond mischaracterizing the law, Illumina attempts to obfuscate issues by
`
`alleging that Columbia’s motion requests this Court take judicial notice of the fact
`
`that the methyl capping group is unsuitable for SBS. D.I. 53 at 2 (“Columbia
`
`improperly asks this Court to evaluate new materials and make factual
`
`determinations about the substance of those materials.”). Columbia makes no such
`
`request, and Illumina’s cited case law is thus inapposite. Instead, Columbia’s
`
`motion merely requests this Court take notice of Illumina’s IPR2020-00988
`
`Petition and Expert Declaration. Judicial notice of these documents is necessary to
`
`allow consideration during the upcoming oral argument of Illumina’s statements
`
`
`
`
`3
`
`
`
`Case: 19-2302 Document: 54 Page: 6 Filed: 10/02/2020
`
`
`
`therein regarding the incompatibility of the methyl capping group for SBS, as
`
`compared to Illumina’s positions in this appeal regarding the same issue.
`
`II. CONCLUSION
`
`For the aforementioned reasons and those set forth in Columbia’s motion,
`
`Columbia respectfully requests that the Court take judicial notice of the IPR2020-
`
`00988 documents, which were attached to Columbia’s motion as Exhibits A and B
`
`to the Declaration of John D. Murnane.
`
`Dated: October 2, 2020
`
`Respectfully submitted,
`
`
`
`
`
`/s/ John D. Murnane
`John D. Murnane
`VENABLE LLP
`1290 Avenue of the Americas
`New York, New York 10104
`(212) 218-2527
`JDMurnane@Venable.com
`
`Counsel for Appellant
`
`
`
`4
`
`
`
`
`
`
`Case: 19-2302 Document: 54 Page: 7 Filed: 10/02/2020
`
`
`
`CERTIFICATE OF COMPLIANCE
`
`This reply complies with the type-volume limitation of Federal Rule of
`
`Appellate Procedure 27(d)(2) because it contains 790 words. This reply complies
`
`with typeface requirements of Federal Rule of Appellate Procedure 32(a)(5) and
`
`the typestyle requirements of Federal Rule of Appellate Procedure 32(a)(6). This
`
`reply has been prepared using Microsoft Word in 14-point Times New Roman.
`
`Dated: October 2, 2020
`
`Respectfully submitted,
`
`
`
`
`
`/s/ John D. Murnane
`John D. Murnane
`VENABLE LLP
`1290 Avenue of the Americas
`New York, New York 10104
`(212) 218-2527
`JDMurnane@Venable.com
`
`Counsel for Appellant
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case: 19-2302 Document: 54 Page: 8 Filed: 10/02/2020
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on October 2, 2020, the foregoing Reply in Support of
`
`Appellant’s Motion for Judicial Notice was served on counsel of record by
`
`electronic means (e-mail and CM/ECF).
`
`Dated: October 2, 2020
`
`Respectfully submitted,
`
`
`
`
`
`/s/ John D. Murnane
`John D. Murnane
`VENABLE LLP
`1290 Avenue of the Americas
`New York, New York 10104
`(212) 218-2527
`JDMurnane@Venable.com
`
`
`
`Counsel for Appellant
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`